Priority Review Sets Up Sanofi’s ‘Best In Disease’ Hemophilia Drug For 2023 Launch

Will Beat Gene Therapy To US Market

Aug 30 2022

Sanofi looks to be on course to gain US approval by early 2023. • Source: Shutterstock